BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 237906)

  • 1. The extended active site of guinea pig liver transglutaminase.
    Gross M; Whetzel NK; Folk JE
    J Biol Chem; 1975 Jun; 250(12):4648-55. PubMed ID: 237906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit liver transglutaminase: physical, chemical, and catalytic properties.
    Abe T; Chung SI; DiAugustine RP; Folk JE
    Biochemistry; 1977 Dec; 16(25):5495-501. PubMed ID: 21685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of guinea pig liver transglutaminase toward ester analogs of amide substrates.
    Gross M; Folk JE
    J Biol Chem; 1974 May; 249(10):3021-5. PubMed ID: 4151487
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates.
    Case A; Stein RL
    Biochemistry; 2003 Aug; 42(31):9466-81. PubMed ID: 12899634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies of guinea pig liver transglutaminase reveal a general-base-catalyzed deacylation mechanism.
    Leblanc A; Gravel C; Labelle J; Keillor JW
    Biochemistry; 2001 Jul; 40(28):8335-42. PubMed ID: 11444980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
    Gorman JJ; Folk JE
    J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the active sites of transglutaminases. I. Activity of the guinea pig liver enzyme toward aliphatic amides.
    Gross M; Folk JE
    J Biol Chem; 1973 Feb; 248(4):1301-6. PubMed ID: 4405642
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the mechanism of glutamine synthetase utilizing pH-dependent behavior in catalysis and binding.
    Colanduoni J; Nissan R; Villafranca JJ
    J Biol Chem; 1987 Mar; 262(7):3037-43. PubMed ID: 2880845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides.
    Gorman JJ; Folk JE
    J Biol Chem; 1981 Mar; 256(6):2712-5. PubMed ID: 6110660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of guinea pig liver transglutaminase for amine substrates.
    Lorand L; Parameswaran KN; Stenberg P; Tong YS; Velasco PT; Jönsson NA; Mikiver L; Moses P
    Biochemistry; 1979 May; 18(9):1756-65. PubMed ID: 35225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkyl isocyanates as active site-directed inactivators of guinea pig liver transglutaminase.
    Gross M; Whetzel NK; Folk JE
    J Biol Chem; 1975 Oct; 250(19):7693-9. PubMed ID: 240837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme.
    Gorman JJ; Folk JE
    J Biol Chem; 1984 Jul; 259(14):9007-10. PubMed ID: 6146608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.
    Marrano C; de Macédo P; Gagnon P; Lapierre D; Gravel C; Keillor JW
    Bioorg Med Chem; 2001 Dec; 9(12):3231-41. PubMed ID: 11711299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amine binding sites in acyl intermediates of transglutaminases. Human blood plasma enzyme (activated coagulation factor XIII) and guinea pig liver enzyme.
    Gross M; Whetzel NK; Folk JE
    J Biol Chem; 1977 Jun; 252(11):3752-9. PubMed ID: 16916
    [No Abstract]   [Full Text] [Related]  

  • 15. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of selective inhibitors of transglutaminase. Phenylthiourea derivatives.
    Lee KN; Fesus L; Yancey ST; Girard JE; Chung SI
    J Biol Chem; 1985 Nov; 260(27):14689-94. PubMed ID: 2865262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase-catalysed incorporation of putrescine into denatured cytochrome. Preparation of a mono-substituted derivative reactive with cytochrome c oxidase.
    Butler SJ; Landon M
    Biochim Biophys Acta; 1981 Sep; 670(2):214-21. PubMed ID: 6117326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the active sites of transglutaminases. II. Activity of the guinea pig liver enzyme toward methylglutamine peptide derivatives.
    Gross M; Folk JE
    J Biol Chem; 1973 Sep; 248(18):6534-42. PubMed ID: 4730329
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of substrate specificities of transglutaminases using synthetic peptides as acyl donors.
    Ohtsuka T; Ota M; Nio N; Motoki M
    Biosci Biotechnol Biochem; 2000 Dec; 64(12):2608-13. PubMed ID: 11210124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase-catalyzed cross-linking through diamines and polyamines.
    Schrode J; Folk JE
    J Biol Chem; 1978 Jul; 253(14):4837-40. PubMed ID: 27507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.